Attention-deficit hyperactivity disorder (ADHD) is a neurodevelopmental disorder estimated to affect approximately 2.5% of children and adults worldwide. The disorder is characterized by the inability to pay attention to ...
While early treatment of diabetes-related eye disease slowed progression to severe disease, it did not improve visual acuity compared with treating more severe disease once it developed, according to a clinical study from ...
Feb 7, 2023
0
61
Visual acuity (VA) is better when tested in the clinic versus at home, according to a research letter published online Aug. 18 in JAMA Ophthalmology.
Aug 25, 2022
0
4
Clinical trial results from the DRCR Retina Network suggest that a specific step strategy, in which patients with diabetic macular edema start with a less expensive medicine and switch to a more expensive medicine if vision ...
Jul 14, 2022
0
79
Researchers from the National Eye Institute (NEI) have identified a new disease that affects the macula, a small part of the light-sensing retina needed for sharp, central vision. Scientists report their findings on the novel ...
Jun 9, 2022
0
95
New research shows that a treatment for retinal vein occlusion yields long-lasting vision gains, with visual acuity remaining significantly above baseline at five years. However, many patients require ongoing treatment. Retinal ...
Apr 21, 2022
0
14
Measurements for three at-home self-administered visual acuity (VA) tests were within one line of Snellen acuity compared within-office VA measurements, according to a study published online March 31 in JAMA Ophthalmology.
Apr 1, 2022
0
5
A retinal stem cell patch developed through a collaboration of researchers at UC Santa Barbara, University of Southern California and California Institute of Technology continues to make progress in its bid to secure approval ...
Mar 16, 2022
0
54
Researchers at Indiana University School of Medicine, in collaboration with the University of Alabama at Birmingham and five other institutions, are investigating novel regenerative medicine approaches to better manage vascular ...
Mar 10, 2022
0
72
(HealthDay)—Faricimab is noninferior to aflibercept for the treatment of neovascular age-related macular degeneration (nAMD) and diabetic macular edema, according to two studies published online Jan. 24 in The Lancet.
Feb 2, 2022
0
2
